1,115
edits
Changes
DMF Sodium Butyrate and Saccharin-LiCl CTA (view source)
Revision as of 11:03, 5 July 2022
, 11:03, 5 July 2022no edit summary
Line 1:
Line 1:
−
+
Test if systemic Sodium Butyrate (NaB), an HDAC inhibitor, enhances CTA learning .
+Test if systemic Sodium Butyrate (NaB), an HDAC inhibitor, enhances CTA learning.
+{{Infobox experiment|align=right
+| Name = Butyrate and Lithium-CTA pt1
+| project = Histone Acetylation
+| code = DMF
+| protocol = 1917
+| funding = Chair's Fund
+| investigators = Mukherjee, Houpt
+| species = rat
+| date = 2020-10-9
+| type = CTA
+| drugs = butyrate, lithium
+| data = https://houptlab.org/bartab/expt/?id=DMG
+}}
+(see replication to increase N at [[DMG Sodium Butyrate and Saccharin-LiCl CTA]])
(see replication to increase N at [[DMG Sodium Butyrate and Saccharin-LiCl CTA]])
Line 69:
Line 84:
−[[Category:Taste Aversion]]
+[[Category:Taste Aversion|CTA Experiments|Epigenetics]]